The Relative Strength (RS) Rating for Steris entered a new percentile Friday, with a rise from 61 to 84.
Risk Management In The Stock Market: How Much Money To Invest Now
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best-performing stocks typically have an RS Rating of above 80 as they launch their biggest climbs.
Steris is now considered extended and out of buy range after clearing a 236.83 buy point in a first-stage flat base. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Earnings growth moved up in the company's latest report from 11% to 14%, but sales fell from 6% to 4%.
The company earns the No. 5 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
